- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Blindness Disease Gene Isolated
25 November 1996 7:00 pm
Scientists have isolated a gene that causes Leber's congenital amaurosis (LCA), a disorder that destroys its victims' vision within the first few months of life. The finding could someday lead to a cure for LCA, which is responsible for a few thousand cases of inherited blindness each year.
A team of French and American scientists at several institutes pinpointed mutations in the retinal guanylate cyclase (RETGC) gene in eight families in which the disease has struck. They report their findings in the December issue of Nature Genetics.
The scientists have an idea how the genetic error leads to retinal degeneration. In a normal retina, an enzyme cascade is activated when the retina processes light, and a second set of biochemical reactions takes place when the cells rest. A compound called cyclic GMP regulates this activity. But if the RETGC gene is flawed, cyclic GMP levels never reach those necessary to trigger the reactions that take place during the recovery stage. "This constant light causes the degradation of the retina," says Steven Pittler, a molecular biologist at the University of South Alabama in Mobile and one of the paper's authors.
The study is a "real landmark" because so little has been known about LCA, the only inherited disease of the retina that strikes early in childhood, says Samuel Jacobson, an ophthalmologist at the University of Pennsylvania's Sheie Eye Institute. Other experts are hailing the finding as the first step toward a cure or gene therapy for LCA. According to Gerald Chader, chief scientific officer for the Foundation Fighting Blindness in Baltimore, the discovery should "put Leber's right now into the forefront for genetic testing."